Combination therapy with mocetinostat, an oral, spectrum-selective histone deacetylase (HDAC) inhibitor, and 5-azaciditine: Indication of clinical activity in MDS Meeting Abstract
| Authors: | Garcia Manero, G.; Selina, L.; Virginia, K.; Maureen, C.; Besa, E. C.; Rossetti, J. M.; Chao, R.; Humphrey, R.; Silverman, L. R. |
| Abstract Title: | Combination therapy with mocetinostat, an oral, spectrum-selective histone deacetylase (HDAC) inhibitor, and 5-azaciditine: Indication of clinical activity in MDS |
| Meeting Title: | 55th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 122 |
| Issue: | 21 |
| Meeting Dates: | 2013 Dec 7-10 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2013-11-15 |
| Language: | English |
| ACCESSION: | WOS:000331385003188 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V122.21.1550.1550 |
| Notes: | Meeting Abstract: 1550 -- Source: Wos |
